Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Triethylamine → [1-[[(1H-Benzimidazol-2-ylmethyl)amino]carbonyl]-2-methylbutyl]carbamic acid 1,1-dimethylethyl ester
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Triethylamine | HCID 8471 | — |
| 반응물 | Benzimidazol-2-ylmethylamine dihydrochloride hydrate | HCID 145819 | — |
| 반응물 | Benzotriazol-1-yloxy-tris(dimethylamino)phosphonium hexafluorophosphate | HCID 151348 | — |
| 반응물 | tert-Butoxycarbonyl-L-isoleucine | HCID 2724762 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 생성물 | [1-[[(1H-Benzimidazol-2-ylmethyl)amino]carbonyl]-2-methylbutyl]carbamic acid 1,1-dimethylethyl ester | HCID 67747066 | 88.4% |
반응 단계
The title compound is prepared by the procedure of Example 1 using 0.505 g of N-(tert-butoxycarbonyl)-L-isoleucine in 10 ml of methylene chloride, 0.500 g of 2-(aminomethyl)benzimidazole dihydrochloride hydrate, 1.07 g of BOP, and 0,850 g of triethylamine. Purification by chromatography (75 g Silica gel; 70% ethyl acetate/hexane) gives 0.669 g of the desired product.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US05430150 |
| 출처 데이터셋 | uspto-grants-1995_07 |
| ORD ID | ord-7096213deeb64948bdecfd6cbc428085 |
| 출처 메모 | uspto-grants-1995_07 |